These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12351643)

  • 1. Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion.
    Gosavi N; Lee HJ; Lee JS; Patel S; Lee SJ
    J Biol Chem; 2002 Dec; 277(50):48984-92. PubMed ID: 12351643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.
    Lee HJ; Lee SJ
    J Biol Chem; 2002 Dec; 277(50):48976-83. PubMed ID: 12351642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.
    Lee HJ; Khoshaghideh F; Patel S; Lee SJ
    J Neurosci; 2004 Feb; 24(8):1888-96. PubMed ID: 14985429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors.
    Lee HJ; Shin SY; Choi C; Lee YH; Lee SJ
    J Biol Chem; 2002 Feb; 277(7):5411-7. PubMed ID: 11724769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of alpha-synuclein aggregate morphology on solution conditions.
    Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
    J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.
    Rideout HJ; Dietrich P; Wang Q; Dauer WT; Stefanis L
    J Biol Chem; 2004 Nov; 279(45):46915-20. PubMed ID: 15322100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Selectivity and Sensitivity of Oligomeric p-Phenylene Ethynylenes for Detecting Fibrillar and Prefibrillar Amyloid Protein Aggregates.
    Fanni AM; Monge FA; Lin CY; Thapa A; Bhaskar K; Whitten DG; Chi EY
    ACS Chem Neurosci; 2019 Mar; 10(3):1813-1825. PubMed ID: 30657326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-synucleinopathies].
    Ferrer I
    Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species.
    Dedmon MM; Christodoulou J; Wilson MR; Dobson CM
    J Biol Chem; 2005 Apr; 280(15):14733-40. PubMed ID: 15671022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of dopamine transporter activity by alpha-synuclein.
    Wersinger C; Sidhu A
    Neurosci Lett; 2003 Apr; 340(3):189-92. PubMed ID: 12672538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.
    Lee FJ; Liu F; Pristupa ZB; Niznik HB
    FASEB J; 2001 Apr; 15(6):916-26. PubMed ID: 11292651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
    Lee EN; Cho HJ; Lee CH; Lee D; Chung KC; Paik SR
    Biochemistry; 2004 Mar; 43(12):3704-15. PubMed ID: 15035641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
    J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein.
    Lee HJ; Khoshaghideh F; Lee S; Lee SJ
    Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
    Sidhu A; Wersinger C; Vernier P
    FASEB J; 2004 Apr; 18(6):637-47. PubMed ID: 15054086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
    Souza JM; Giasson BI; Chen Q; Lee VM; Ischiropoulos H
    J Biol Chem; 2000 Jun; 275(24):18344-9. PubMed ID: 10747881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C; Vernier P; Sidhu A
    Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum.
    Qin Y; Ouyang Q; Pablo J; Mash DC
    Neuroreport; 2005 Sep; 16(13):1489-93. PubMed ID: 16110277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
    Lee SJ
    Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.